{
  "id": 19502277,
  "title": "Earnings call transcript: Viveo beats Q3 2026 estimates as restructuring gains traction",
  "url": "https://urgent.news/2026/11/11/earnings-call-transcript-viveo-beats-q3-2026-estimates-as",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-11T13:58:16.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-viveo-beats-q3-2026-estimates-as-restructuring-gains-traction-93CH-5019078"
  },
  "original_language": "en",
  "account": "Vivo, a Brazilian healthcare company, reported better-than-expected results in Q3 2026, despite facing challenges. The company posted adjusted earnings per share of -$0.0858, surpassing the expected -$0.24. Revenue reached $2.99 billion, exceeding the forecast of $2.92 billion. Net revenue grew 7.8% year-over-year to BRL 3.55 billion, driven by strong performance in hospital and clinic sales, which increased 18.9% quarter-over-quarter. Adjusted EBITDA rose 13.1% year-over-year, with a margin of 6.4%. Free cash flow increased 51.4% to BRL 150 million. Management highlighted a successful restructuring, including a capital increase and debt reduction, which contributed to improved financial metrics. Despite a fire at the Cremer facility and other near-term pressures, Vivo demonstrated progress in cost reduction, margin improvement, and balance sheet strengthening.",
  "summary": null,
  "key_points": [
    "Vivo beats Q3 2026 estimates with -$0.0858 EPS",
    "Revenue reaches $2.99 billion, up 2.3% year-over-year",
    "Restructuring efforts improve margins and balance sheet"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}